the caspian versus impower133 regimen
Published 4 years ago • 547 plays • Length 6:32Download video MP4
Download video MP3
Similar videos
-
7:20
small-cell lung cancer: the impower133 and caspian trials
-
4:34
discussion of impower133 and caspian trials
-
6:37
caspian trial: durvalumab and chemotherapy in es-sclc
-
8:11
first-line immunotherapy: impower133 regimen
-
1:50
small cell lung cancer: interpreting data from impower133
-
4:18
tecentriq branded moa video
-
1:42
live your best life – cochlear kanso sound processor recipient, jerome e.
-
12:11
enhanced mitochondrial fusion suppresses pancreatic cancer
-
7:13
i/o chemotherapy in treatment-naïve es-sclc
-
4:57
chemoimmunotherapy for es sclc: caspian trial
-
3:44
the caspian trial in extensive-stage sclc
-
2:07
dr. chen on the impact of the pivotal impower133 trial on sclc
-
5:22
chemoimmunotherapy for es sclc: impower133 trial
-
6:33
a win for small–cell lung cancer: impower 133
-
4:40
emerging therapies for extensive stage sclc and caspian trial
-
2:07
extensive-stage sclc: potential in the caspian trial
-
5:07
recent progress in the treatment of sclc
-
7:35
i-o therapy versus surgery or chemotherapy in nsclc
-
5:06
impower133 in sclc
-
5:23
atezolizumab carboplatin/etoposide for extensive-stage small cell lung cancer: impower133 update
-
1:27
fda approval of atezolizumab for nsclc
-
1:22
dr. horn on updated data from impower133 in small cell lung cancer